CVE-2022-36634
An access control issue in ZKTeco ZKBioSecurity V5000 3.0.5_r allows attackers to arbitrarily...
An access control issue in ZKTeco ZKBioSecurity V5000 3.0.5_r allows attackers to arbitrarily create admin users via a crafted HTTP request.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
An access control issue in ZKTeco ZKBioSecurity V5000 3.0.5_r allows attackers to arbitrarily create admin users via a crafted HTTP request.
- Record
CVE-2022-36634- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-863
- Updated
- 2026-11-02
CVE List No score
An access control issue in ZKTeco ZKBioSecurity V5000 3.0.5_r allows attackers to arbitrarily create admin users via a crafted HTTP request.
- Record
CVE-2022-36634- Updated
- 2026-11-02
EUVDEUVD-2022-39337 No score
An access control issue in ZKTeco ZKBioSecurity V5000 3.0.5_r allows attackers to arbitrarily create admin users via a crafted HTTP request.
- Record
EUVD-2022-39337- Updated
- 2026-11-02
GitHub AdvisoriesGHSA-8w2f-h97j-qw93
An access control issue in ZKTeco ZKBioSecurity V5000 3.0.5_r allows attackers to arbitrarily...
An access control issue in ZKTeco ZKBioSecurity V5000 3.0.5_r allows attackers to arbitrarily create admin users via a crafted HTTP request.
- Record
GHSA-8w2f-h97j-qw93- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-863
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2022-36634 is a high vulnerability (CVSS 8.8) in Zkteco Zkbiosecurity V5000, published October 7, 2022. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.25%, the 69th percentile. No source names a fixed version.